摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7‐amino‐5‐(2‐fluorophenyl)‐6‐cyano‐5H‐pyrano[2,3‐d]pyrimidin‐(1H,3H)-2,4‐dione

中文名称
——
中文别名
——
英文名称
7‐amino‐5‐(2‐fluorophenyl)‐6‐cyano‐5H‐pyrano[2,3‐d]pyrimidin‐(1H,3H)-2,4‐dione
英文别名
7-amino-5-(2-fluorophenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile;7-amino-5-(2-fluorophenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile;7-amino-5-(2-fluorophenyl)-2,4-dioxo-1,5-dihydropyrano[2,3-d]pyrimidine-6-carbonitrile
7‐amino‐5‐(2‐fluorophenyl)‐6‐cyano‐5H‐pyrano[2,3‐d]pyrimidin‐(1H,3H)-2,4‐dione化学式
CAS
——
化学式
C14H9FN4O3
mdl
——
分子量
300.249
InChiKey
USICXLQDYHLVTH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    22
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    117
  • 氢给体数:
    3
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    巴比妥酸2-氟苯甲醛丙二腈 在 erbium-folic acid-coated CoFe2O4 nanoparticles 作用下, 以 neat (no solvent) 为溶剂, 反应 0.5h, 以88%的产率得到7‐amino‐5‐(2‐fluorophenyl)‐6‐cyano‐5H‐pyrano[2,3‐d]pyrimidin‐(1H,3H)-2,4‐dione
    参考文献:
    名称:
    铒-叶酸包覆的CoFe2O4配合物催化吡喃[2,3-d]嘧啶酮和二氢吡喃[3,2-c]色烯化合物绿色一锅三组分合成的新进展
    摘要:
    在当前的研究中,非常关注异质化纳米结构。在此,我们报告了通过固定包覆有叶酸 (FA) 的铒 (Er) 来制备铁氧体钴的绿色合成磁性纳米粒子 (MNP),该纳米粒子显示出有效的催化性能和可回收性。使用场发射扫描电子显微镜 (FE-SEM)、透射电子显微镜 (TEM)、能量色散 X 射线光谱 (EDX)、X 射线原子映射、热重分析 (TGA)、X 射线衍射 ( XRD), 振动样品磁强计 (VSM), i进行了电感耦合等离子体发射光谱(ICP-OES)和傅里叶变换红外(FT-IR)光谱技术来揭示所制备磁性催化剂的结构特性。所获得的纳米杂化复合物作为高效、可回收、绿色的异质体系,为制备吡喃并[2,3- d ]嘧啶酮和二氢吡喃并[3,2- c ]铺平了道路]色烯衍生物,通过各种醛、丙二腈和羟基香豆素或巴比妥酸在绿色条件下的一锅三组分缩合反应。这种易于制备的有机金属催化剂具有许多优点,例如操作简单、
    DOI:
    10.1002/aoc.6225
点击查看最新优质反应信息

文献信息

  • Synthesis of chloro, fluoro, and nitro derivatives of 7‐amino‐5‐aryl‐6‐cyano‐5<i>H</i>‐pyrano pyrimidin‐2,4‐diones using organic catalysts and their antimicrobial and anticancer activities
    作者:Oluwole S. Aremu、Parvesh Singh、Moganavelli Singh、Chunderika Mocktar、Neil A. Koorbanally
    DOI:10.1002/jhet.3695
    日期:2019.11
    Chloro, fluoro, and nitro derivatives of 7‐amino‐5‐aryl‐6‐cyano‐5H‐pyrano pyrimidin‐2,4‐diones were produced by reacting malononitrile, barbituric acid, and aromatic aldehydes together with a DABCO catalyst in an aqueous one‐pot reaction. This is the first report of these compounds being synthesized with DABCO as a catalyst, which produced the compounds in yields in excess of 90%. The 2,4‐difluoro
    通过使丙二腈巴比妥酸和芳族醛与DABCO催化剂在甲醇中反应,制得7-基-5-芳基-6-基-5 H-嘧啶-2,4-二酮的和硝基衍生物一锅反应。这是用DABCO作为催化剂合成这些化合物的第一个报道,该化合物生产的化合物收率超过90%。2,4-二生物(11)是新颖的。借助1 H,13 C和2D NMR光谱对合成的化合物的结构进行了阐明。化合物2(2-Cl衍生物)对黄色葡萄球菌和MRSA的MBC值均<200μM ,而2-硝基衍生物5对革兰氏大肠杆菌的MBC为191μM 。还测试了合成的化合物对HeLa细胞系的抗癌活性,该化合物中的所有化合物均比常用的抗癌药物5-尿嘧啶表现出更好的活性(IC 50值在129μM和340μM之间)。
查看更多

同类化合物

叔-丁基2-(甲磺酰)-5,7-二氢螺[吡喃并[4,3-D]嘧啶并-8,3-吡咯烷]-1-甲酸基酯 乙基7'-氨基-6-氟-2,2',4'-三羰基-1,1',2,2',3',4'-六氢螺[吲哚-3,5'-吡喃并[2,3-d]嘧啶]-6'-羧酸酯 7H-吡喃并[2,3-d]嘧啶-7-酮 7H-吡喃并[2,3-d]嘧啶 7,8-二氢-5H-吡喃并[4,3-D]嘧啶-2-胺 5H-吡喃并[4,3-d]嘧啶 5H-吡喃并[2,3-d]嘧啶 2H-吡喃并[2,3-d]嘧啶-6-甲腈,7-氨基-1,3,4,5-四氢-5-(4-甲氧苯基)-2,4-二羰基- 2,4-二氯-7,8-二氢-5H-吡喃[4,3-d]嘧啶 1H-吡喃并[3,4-d]嘧啶 1H-吡喃并[3,2-d]嘧啶 (5S,7R,8S)-2-methylsulfanyl-5,8-dihydro-7-allyloxymethyl-5-methoxy-pyrano[3,4-d]-pyrimidin-8-ol 5-ethyl-2-[(Z)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-ethyl-2-[[1-(3-methylbutanoyl)piperidin-4-ylidene]amino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-butyl-2-[(E)-1-(4-cyclohexylpiperazin-1-yl)butylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 2,3,3a,9-tetrahydro-5-iodo-2,3,3-trimethylimidazo[5,1-b][1,3]benzoxazin-1-one 2,4-dimethyl-9-methoxy-4,12b-dihydro-1H,7H-chromeno[4',3'-4,5]pyrano[2,3-d]pyrimidine-1,3(2H)-dione 5-methyl-3-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)-oxazolidin-5-yl]-propyl}-1H-quinazoline-2,4-dione 7-amino-2-(benzothiazol-2-ylmethyl)-9-phenylthiazolo[4',5':6,5]pyrano[2,3-d]pyrimidine-8(7H)-one 2-[6-[(2-chlorophenyl)methyl]pyridin-2-yl]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine 8-amino-2-(methylthio)-5-oxo-6-(pyridin-4-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 5-(4-chlorophenyl)-1,3,8,8-tetramethyl-7,9-dihydro-5H-chromeno[2,3-d]pyrimidine-2,4,6-trione ethyl 7'-amino-2,4'-dioxo-2'-thioxo-1,1',2,2',3',4'-hexahydrospiroindole-3,5'-pyrano[2,3-d]pyrimidine-6'-carboxylate 8-amino-2-(methylthio)-5-oxo-6-(pyridin-3-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 7-Amino-4-oxo-5-phenyl-2-thioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylic acid ethyl ester 3-(1H-benzoimidazol-2-yl)-3-butyl-5-methyl-dihydro-furan-2-one 3-(1H-benzoimidazol-2-yl)-3-(2-diethylamino-ethyl)-5-methyl-dihydro-furan-2-one 1-{4-[(1R,9S)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea (S)-6-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyridin-2(1H)-one 3-(1H-benzoimidazol-2-yl)-5-methyl-3-(3-methyl-butyl)-dihydro-furan-2-one 13-(3,4-dimethoxyphenyl)-5,5-dimethyl-2-thioxo-2,5,6,8,9,13-hexahydro-4H-pyrimido[5',4':6,7][1,8]naphthyridino[4,3,2-de]quinazoline-10,12(3a1H,11H)-dione (S)-3-allyl-8-ethyl-4,7-dioxo-2-(phenylcarbamoyl)-4,5,7,8-tetrahydro-3H-pyrano[4,3-d]pyrimidin-8-yl acetate 8-{[(2-bromo-3-methylphenyl)oxy]methyl}-1,3-dimethyl-2,3,4,6-tetrahydro-1H-pyrano[3,2-d]pyrimidine-2,4-dione 9-ethyl-6a-methyl-2-phenyl-8,9-dihydro-oxazolo[2,3-b]pyrimido[4,5-d][1,3]oxazin-5-one (S)-1-cyclobutyl-3-(4-(4-(3-methylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenyl)urea (S)-2-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyrimidin-4(3H)-one (6aRS,10aRS)-4,6,6a,7,8,9,10,10a-octahydro-2,4,6,6-tetramethyl-1H-<2>benzopyrano<3,4-d>pyrimidine-1,3(2H)-dione 5-ethyl-2-[(E)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione N3-(methyl 4-deoxy-α-L-threo-hex-4-enopyranosyluronate)-5-fluorouracil 1-{4-[(1S,9R)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea 4,5-dimethyl-12-(4-methoxyphenyl)-2-thioxo-2,4a,7,8,9,10,11,12-octahydrodipyrimido[4,5-b;4',5'-f] [1,8]naphthyridine-9,11-dione 2-[4-[2-hydroxyethyl(methyl)amino]-2-methyl-7-oxopyrimido[5,4-b][1,4]oxazin-8-yl]acetonitrile 5-ethyl-2-[(Z)-1-thiophen-2-ylethylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione